Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses

ABSTRACT The ongoing emergence of new variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) underscores the urgent need for developing antivirals targeting both SARS‐CoV‐2 variants and related sarbecoviruses. To this end, we designed novel trispecific antibodies, Tri‐1 and Tri...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rui Qiao, Yuanchen Liu, Qiyu Mao, Jiayan Li, Yinying Lu, Jialu Shi, Chen Li, Jizhen Yu, Jiami Gong, Xun Wang, Yuchen Shao, Lei Sun, Wenhong Zhang, Hongjie Yu, Hin Chu, Pengfei Wang, Xiaoyu Zhao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-05-01
Colecção:	MedComm
Assuntos:	coronavirus sarbecovirus SARS‐CoV‐2 bispecific antibody trispecific antibody broadly neutralizing antibody
Acesso em linha:	https://doi.org/10.1002/mco2.70191
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!